Lung Cancer Surgery Market Size, Share, Trends, Growth 2032

Lung Cancer Surgery Market

Lung Cancer Surgery Market By Type (Surgical Instruments, Monitoring & Visualizing Systems, and Endosurgical Equipment), By Procedure (Robotic Surgery, Thoracotomy, Lobectomy, Sleeve Resection, Endobronchial Surgery, Pneumonectomy, Percutaneous Surgery, Segmentectomy, and Minimally Invasive Surgeries), By Treatment (Hospitals, Clinics, Ambulatory Surgical Centers, and Research Laboratories): Global Industry Perspective, Comprehensive Analysis and Forecast, 2024 - 2032-

Category: Healthcare Report Format : PDF Pages: 180 Report Code: ZMR-589 Published Date: Nov-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 1327.2 Million USD 2223.31 Million 5.9% 2023

Table Of Content

  • Chapter No. 1: Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2: Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Type
        • 2.1.1.2. Market Attractiveness Analysis, By Procedure
        • 2.1.1.3. Market Attractiveness Analysis, By Treatment
        • 2.1.1.4. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Lung Cancer Surgery Market, 2016 – 2028 (USD Million)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3: COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4: Lung Cancer Surgery Market – Type Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Type, 2020 & 2028
    • 4.2. Surgical Instruments
      • 4.2.1. Market Size and Forecast, By Region (USD Million)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.3. Monitoring & Visualizing Systems
      • 4.3.1. Market Size and Forecast, By Region (USD Million)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.4. Endosurgical Equipment
      • 4.4.1. Market Size and Forecast, By Region (USD Million)
      • 4.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.4.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 5: Lung Cancer Surgery Market – Procedure Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By Procedure, 2020 & 2028
    • 5.2. Robotic Surgery
      • 5.2.1. Market Size and Forecast, By Region (USD Million)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. Thoracotomy
      • 5.3.1. Market Size and Forecast, By Region (USD Million)
      • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.4. Lobectomy
      • 5.4.1. Market Size and Forecast, By Region (USD Million)
      • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.5. Sleeve Resection
      • 5.5.1. Market Size and Forecast, By Region (USD Million)
      • 5.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.5.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.6. Endobronchial Surgery
      • 5.6.1. Market Size and Forecast, By Region (USD Million)
      • 5.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.6.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.7. Pneumonectomy
      • 5.7.1. Market Size and Forecast, By Region (USD Million)
      • 5.7.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.7.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.8. Percutaneous Surgery
      • 5.8.1. Market Size and Forecast, By Region (USD Million)
      • 5.8.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.8.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.9. Segmentectomy
      • 5.9.1. Market Size and Forecast, By Region (USD Million)
      • 5.9.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.9.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.10. Minimally Invasive Surgeries
      • 5.10.1. Market Size and Forecast, By Region (USD Million)
      • 5.10.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.10.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 6: Lung Cancer Surgery Market – Treatment Segment Analysis
    • 6.1. Overview
      • 6.1.1. Market Revenue Share, By Treatment, 2020 & 2028
    • 6.2. Hospitals
      • 6.2.1. Market Size and Forecast, By Region (USD Million)
      • 6.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.3. Clinics
      • 6.3.1. Market Size and Forecast, By Region (USD Million)
      • 6.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.4. Ambulatory Surgical Centers
      • 6.4.1. Market Size and Forecast, By Region (USD Million)
      • 6.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.5. Research Laboratories
      • 6.5.1. Market Size and Forecast, By Region (USD Million)
      • 6.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.5.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 7: Lung Cancer Surgery Market – Regional Analysis
    • 7.1. Overview
      • 7.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 7.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Million)
    • 7.2. North America
      • 7.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.2.2. North America Market Revenue, By Type, 2016 – 2028
      • 7.2.3. North America Market Revenue, By Procedure, 2016 – 2028
      • 7.2.4. North America Market Revenue, By Treatment, 2016 – 2028
      • 7.2.5. U.S.
        • 7.2.5.1. U.S. Market Revenue, By Type, 2016 – 2028
        • 7.2.5.2. U.S. Market Revenue, By Procedure, 2016 – 2028
        • 7.2.5.3. U.S. Market Revenue, By Treatment, 2016 – 2028
      • 7.2.6. Canada
        • 7.2.6.1. Canada Market Revenue, By Type, 2016 – 2028
        • 7.2.6.2. Canada Market Revenue, By Procedure, 2016 – 2028
        • 7.2.6.3. Canada Market Revenue, By Treatment, 2016 – 2028
      • 7.2.7. Mexico
        • 7.2.7.1. Mexico Market Revenue, By Type, 2016 – 2028
        • 7.2.7.2. Mexico Market Revenue, By Procedure, 2016 – 2028
        • 7.2.7.3. Mexico Market Revenue, By Treatment, 2016 – 2028
    • 7.3. Europe
      • 7.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.3.2. Europe Market Revenue, By Type, 2016 – 2028
      • 7.3.3. Europe Market Revenue, By Procedure, 2016 – 2028
      • 7.3.4. Europe Market Revenue, By Treatment, 2016 – 2028
      • 7.3.5. Germany
        • 7.3.5.1. Germany Market Revenue, By Type, 2016 – 2028
        • 7.3.5.2. Germany Market Revenue, By Procedure, 2016 – 2028
        • 7.3.5.3. Germany Market Revenue, By Treatment, 2016 – 2028
      • 7.3.6. France
        • 7.3.6.1. France Market Revenue, By Type, 2016 – 2028
        • 7.3.6.2. France Market Revenue, By Procedure, 2016 – 2028
        • 7.3.6.3. France Market Revenue, By Treatment, 2016 – 2028
      • 7.3.7. U.K.
        • 7.3.7.1. U.K. Market Revenue, By Type, 2016 – 2028
        • 7.3.7.2. U.K. Market Revenue, By Procedure, 2016 – 2028
        • 7.3.7.3. U.K. Market Revenue, By Treatment, 2016 – 2028
      • 7.3.8. Italy
        • 7.3.8.1. Italy Market Revenue, By Type, 2016 – 2028
        • 7.3.8.2. Italy Market Revenue, By Procedure, 2016 – 2028
        • 7.3.8.3. Italy Market Revenue, By Treatment, 2016 – 2028
      • 7.3.9. Spain
        • 7.3.9.1. Spain Market Revenue, By Type, 2016 – 2028
        • 7.3.9.2. Spain Market Revenue, By Procedure, 2016 – 2028
        • 7.3.9.3. Spain Market Revenue, By Treatment, 2016 – 2028
      • 7.3.10. Rest of Europe
        • 7.3.10.1. Rest of Europe Market Revenue, By Type, 2016 – 2028
        • 7.3.10.2. Rest of Europe Market Revenue, By Procedure, 2016 – 2028
        • 7.3.10.3. Rest of Europe Market Revenue, By Treatment, 2016 – 2028
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.4.2. Asia Pacific Market Revenue, By Type, 2016 – 2028
      • 7.4.3. Asia Pacific Market Revenue, By Procedure, 2016 – 2028
      • 7.4.4. Asia Pacific Market Revenue, By Treatment, 2016 – 2028
      • 7.4.5. China
        • 7.4.5.1. China Market Revenue, By Type, 2016 – 2028
        • 7.4.5.2. China Market Revenue, By Procedure, 2016 – 2028
        • 7.4.5.3. China Market Revenue, By Treatment, 2016 – 2028
      • 7.4.6. Japan
        • 7.4.6.1. Japan Market Revenue, By Type, 2016 – 2028
        • 7.4.6.2. Japan Market Revenue, By Procedure, 2016 – 2028
        • 7.4.6.3. Japan Market Revenue, By Treatment, 2016 – 2028
      • 7.4.7. India
        • 7.4.7.1. India Market Revenue, By Type, 2016 – 2028
        • 7.4.7.2. India Market Revenue, By Procedure, 2016 – 2028
        • 7.4.7.3. India Market Revenue, By Treatment, 2016 – 2028
      • 7.4.8. South Korea
        • 7.4.8.1. South Korea Market Revenue, By Type, 2016 – 2028
        • 7.4.8.2. South Korea Market Revenue, By Procedure, 2016 – 2028
        • 7.4.8.3. South Korea Market Revenue, By Treatment, 2016 – 2028
      • 7.4.9. South-East Asia
        • 7.4.9.1. South-East Asia Market Revenue, By Type, 2016 – 2028
        • 7.4.9.2. South-East Asia Market Revenue, By Procedure, 2016 – 2028
        • 7.4.9.3. South-East Asia Market Revenue, By Treatment, 2016 – 2028
      • 7.4.10. Rest of Asia Pacific
        • 7.4.10.1. Rest of Asia Pacific Market Revenue, By Type, 2016 – 2028
        • 7.4.10.2. Rest of Asia Pacific Market Revenue, By Procedure, 2016 – 2028
        • 7.4.10.3. Rest of Asia Pacific Market Revenue, By Treatment, 2016 – 2028
    • 7.5. Latin America
      • 7.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.5.2. Latin America Market Revenue, By Type, 2016 – 2028
      • 7.5.3. Latin America Market Revenue, By Procedure, 2016 – 2028
      • 7.5.4. Latin America Market Revenue, By Treatment, 2016 – 2028
      • 7.5.5. Brazil
        • 7.5.5.1. Brazil Market Revenue, By Type, 2016 – 2028
        • 7.5.5.2. Brazil Market Revenue, By Procedure, 2016 – 2028
        • 7.5.5.3. Brazil Market Revenue, By Treatment, 2016 – 2028
      • 7.5.6. Argentina
        • 7.5.6.1. Argentina Market Revenue, By Type, 2016 – 2028
        • 7.5.6.2. Argentina Market Revenue, By Procedure, 2016 – 2028
        • 7.5.6.3. Argentina Market Revenue, By Treatment, 2016 – 2028
      • 7.5.7. Rest of Latin America
        • 7.5.7.1. Rest of Latin America Market Revenue, By Type, 2016 – 2028
        • 7.5.7.2. Rest of Latin America Market Revenue, By Procedure, 2016 – 2028
        • 7.5.7.3. Rest of Latin America Market Revenue, By Treatment, 2016 – 2028
    • 7.6. The Middle-East and Africa
      • 7.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.6.2. The Middle-East and Africa Market Revenue, By Type, 2016 – 2028
      • 7.6.3. The Middle-East and Africa Market Revenue, By Procedure, 2016 – 2028
      • 7.6.4. The Middle-East and Africa Market Revenue, By Treatment, 2016 – 2028
      • 7.6.5. GCC Countries
        • 7.6.5.1. GCC Countries Market Revenue, By Type, 2016 – 2028
        • 7.6.5.2. GCC Countries Market Revenue, By Procedure, 2016 – 2028
        • 7.6.5.3. GCC Countries Market Revenue, By Treatment, 2016 – 2028
      • 7.6.6. South Africa
        • 7.6.6.1. South Africa Market Revenue, By Type, 2016 – 2028
        • 7.6.6.2. South Africa Market Revenue, By Procedure, 2016 – 2028
        • 7.6.6.3. South Africa Market Revenue, By Treatment, 2016 – 2028
      • 7.6.7. Rest of Middle-East Africa
        • 7.6.7.1. Rest of Middle-East Africa Market Revenue, By Type, 2016 – 2028
        • 7.6.7.2. Rest of Middle-East Africa Market Revenue, By Procedure, 2016 – 2028
        • 7.6.7.3. Rest of Middle-East Africa Market Revenue, By Treatment, 2016 – 2028
  • Chapter No. 8: Lung Cancer Surgery Market – Industry Analysis
    • 8.1. Introduction
    • 8.2. Market Drivers
    • 8.3. Market Restraints
    • 8.4. Market Opportunities
    • 8.5. Porter’s Five Forces Analysis
    • 8.6. PEST Analysis
    • 8.7. Regulatory Landscape
    • 8.8. Technulogy Landscape
    • 8.9. Regional Market Trends
      • 8.9.1. North America
      • 8.9.2. Europe
      • 8.9.3. Asia Pacific
      • 8.9.4. Latin America
      • 8.9.5. The Middle-East and Africa
    • 8.10. Pricing Analysis
    • 8.11. Value Chain Analysis
    • 8.12. Downstream Buyers
    • 8.13. Distributors/Traders List
  • Chapter No. 9: Competitive Landscape
    • 9.1. Company Market Share Analysis – 2019
      • 9.1.1. Global Lung Cancer Surgery Market: Company Market Share, 2019
      • 9.1.2. Global Lung Cancer Surgery Market, Company Market Revenue, 2016 – 2019 (USD Million)
      • 9.1.3. Global Lung Cancer Surgery Market, Company Y-o-Y Growth, 2017 – 2019 (%)
      • 9.1.4. Global Lung Cancer Surgery Market: Radar Determinant Chart, 2019
    • 9.2. Strategic Developments
      • 9.2.1. Acquisitions & Mergers
      • 9.2.2. New Product Launch
      • 9.2.3. Regional Expansion
    • 9.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 10: Company Profiles
    • 10.1. Medical Devices Business Services, Inc.
    • 10.2. Intuitive Surgical
    • 10.3. AngioDynamics
    • 10.4. ulympus Corporation
    • 10.5. KARL STORZ SE & Co. KG
    • 10.6. Scanlan International
    • 10.7. TROKAMED GmbH
    • 10.8. Pfizer Inc.
      • 10.9. F.Hoffmann-La Roche Ltd.
    • 10.10. Genentech Inc.
    • 10.11. Boehringer Ingelheim International GmbH
    • 10.12. Abbott
    • 10.13. Boston Scientific Corporation
  • Chapter No. 11: Marketing Strategy Analysis
    • 11.1. Marketing Channel
    • 11.2. Direct Marketing
    • 11.3. Indirect Marketing
    • 11.4. Marketing Channel Development Trends
    • 11.5. Economic/Pulitical Environmental Change
  • Chapter No. 12: Research Methodulogy
    • 12.1. Research Methodulogy
    • 12.2. Phase I - Secondary Research
    • 12.3. Phase II - Data Modeling
      • 12.3.1. Company Share Analysis Model
      • 12.3.2. Revenue Based Modeling
    • 12.4. Phase III - Primary Research
    • 12.5. Research Limitations
      • 12.5.1. Assumptions

Table Of Figures

List of Figures    

FIG NO. 1. Market Attractiveness Analysis, By Type
FIG NO. 2. Market Attractiveness Analysis, By Procedure
FIG NO. 3. Market Attractiveness Analysis, By Treatment
FIG NO. 4. Market Attractiveness Analysis, By Region
FIG NO. 5. Global Lung Cancer Surgery Market Revenue, 2016 – 2028 (USD Million)
FIG NO. 6. Impact of COVID-19 Pandemic in North America Countries
FIG NO. 7. Market Revenue Share, By Type, 2020 & 2028
FIG NO. 8. Global Lung Cancer Surgery Market for Surgical Instruments, Revenue (USD Million) 2016 – 2028
FIG NO. 9. Comparative Revenue Analysis of Lung Cancer Surgery Market for Surgical Instruments, By Country, 2020 & 2028
FIG NO. 10. Global Lung Cancer Surgery Market for Monitoring & Visualizing Systems, Revenue (USD Million) 2016 – 2028
FIG NO. 11. Comparative Revenue Analysis of Lung Cancer Surgery Market for Monitoring & Visualizing Systems, By Country, 2020 & 2028
FIG NO. 12. Global Lung Cancer Surgery Market for Endosurgical Equipment, Revenue (USD Million) 2016 – 2028
FIG NO. 13. Comparative Revenue Analysis of Lung Cancer Surgery Market for Endosurgical Equipment, By Country, 2020 & 2028
FIG NO. 14. Market Revenue Share, By Procedure, 2020 & 2028
FIG NO. 15. Global Lung Cancer Surgery Market for Robotic Surgery, Revenue (USD Million) 2016 – 2028
FIG NO. 16. Comparative Revenue Analysis of Lung Cancer Surgery Market for Robotic Surgery, By Country, 2020 & 2028
FIG NO. 17. Global Lung Cancer Surgery Market for Thoracotomy, Revenue (USD Million) 2016 – 2028
FIG NO. 18. Comparative Revenue Analysis of Lung Cancer Surgery Market for Thoracotomy, By Country, 2020 & 2028
FIG NO. 19. Global Lung Cancer Surgery Market for Lobectomy, Revenue (USD Million) 2016 – 2028
FIG NO. 20. Comparative Revenue Analysis of Lung Cancer Surgery Market for Lobectomy, By Country, 2020 & 2028
FIG NO. 21. Global Lung Cancer Surgery Market for Sleeve Resection, Revenue (USD Million) 2016 – 2028
FIG NO. 22. Comparative Revenue Analysis of Lung Cancer Surgery Market for Sleeve Resection, By Country, 2020 & 2028
FIG NO. 23. Global Lung Cancer Surgery Market for Endobronchial Surgery, Revenue (USD Million) 2016 – 2028
FIG NO. 24. Comparative Revenue Analysis of Lung Cancer Surgery Market for Endobronchial Surgery, By Country, 2020 & 2028
FIG NO. 25. Global Lung Cancer Surgery Market for Pneumonectomy, Revenue (USD Million) 2016 – 2028
FIG NO. 26. Comparative Revenue Analysis of Lung Cancer Surgery Market for Pneumonectomy, By Country, 2020 & 2028
FIG NO. 27. Global Lung Cancer Surgery Market for Percutaneous Surgery, Revenue (USD Million) 2016 – 2028
FIG NO. 28. Comparative Revenue Analysis of Lung Cancer Surgery Market for Percutaneous Surgery, By Country, 2020 & 2028
FIG NO. 29. Global Lung Cancer Surgery Market for Segmentectomy, Revenue (USD Million) 2016 – 2028
FIG NO. 30. Comparative Revenue Analysis of Lung Cancer Surgery Market for Segmentectomy, By Country, 2020 & 2028
FIG NO. 31. Global Lung Cancer Surgery Market for Minimally Invasive Surgeries, Revenue (USD Million) 2016 – 2028
FIG NO. 32. Comparative Revenue Analysis of Lung Cancer Surgery Market for Minimally Invasive Surgeries, By Country, 2020 & 2028
FIG NO. 33. Market Revenue Share, By Treatment, 2020 & 2028
FIG NO. 34. Global Lung Cancer Surgery Market for Hospitals, Revenue (USD Million) 2016 – 2028
FIG NO. 35. Comparative Revenue Analysis of Lung Cancer Surgery Market for Hospitals, By Country, 2020 & 2028
FIG NO. 36. Global Lung Cancer Surgery Market for Clinics, Revenue (USD Million) 2016 – 2028
FIG NO. 37. Comparative Revenue Analysis of Lung Cancer Surgery Market for Clinics, By Country, 2020 & 2028
FIG NO. 38. Global Lung Cancer Surgery Market for Ambulatory Surgical Centers, Revenue (USD Million) 2016 – 2028
FIG NO. 39. Comparative Revenue Analysis of Lung Cancer Surgery Market for Ambulatory Surgical Centers, By Country, 2020 & 2028
FIG NO. 40. Global Lung Cancer Surgery Market for Research Laboratories, Revenue (USD Million) 2016 – 2028
FIG NO. 41. Comparative Revenue Analysis of Lung Cancer Surgery Market for Research Laboratories, By Country, 2020 & 2028
FIG NO. 42. Global Lung Cancer Surgery Market Revenue Share, By Region, 2020 & 2028
FIG NO. 43. North America Lung Cancer Surgery Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 44. Porter’s Five Forces Analysis for Global Lung Cancer Surgery Market
FIG NO. 45. PEST Analysis for Global Lung Cancer Surgery Market
FIG NO. 46. Pricing Analysis for Global Lung Cancer Surgery Market
FIG NO. 47. Value Chain Analysis for Global Lung Cancer Surgery Market
FIG NO. 48. Company Share Analysis, 2019
FIG NO. 49. Radar Determinant Chart, 2019
FIG NO. 50. Company Strategic Developments – Heat Map Analysis
FIG NO. 51. Medical Devices Business Services, Inc. Business Segment Revenue Share, 2020 (%)
FIG NO. 52. Medical Devices Business Services, Inc. Geographical Segment Revenue Share, 2020 (%)
FIG NO. 53. Market Channels
FIG NO. 54. Marketing Channel Development Trend
FIG NO. 55. Growth in World Gross Product, 2008-2018
FIG NO. 56. Research Methodology – Detailed View
FIG NO. 57. Research Methodology


Table Of Tables

List of Tables 

TABLE NO. 1. Global Lung Cancer Surgery Market: Snapshot
TABLE NO. 2. Quarterly Lung Cancer Surgery Market Revenue by Region, 2020
TABLE NO. 3. Quarterly Lung Cancer Surgery Market Revenue Forecast by Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
TABLE NO. 6. Global Lung Cancer Surgery Market for Surgical Instruments, by Region, 2016 – 2028 (USD Million)
TABLE NO. 7. Global Lung Cancer Surgery Market for Monitoring & Visualizing Systems, by Region, 2016 – 2028 (USD Million)
TABLE NO. 8. Global Lung Cancer Surgery Market for Endosurgical Equipment, by Region, 2016 – 2028 (USD Million)
TABLE NO. 9. Global Lung Cancer Surgery Market for Robotic Surgery, by Region, 2016 – 2028 (USD Million)
TABLE NO. 10. Global Lung Cancer Surgery Market for Thoracotomy, by Region, 2016 – 2028 (USD Million)
TABLE NO. 11. Global Lung Cancer Surgery Market for Lobectomy, by Region, 2016 – 2028 (USD Million)
TABLE NO. 12. Global Lung Cancer Surgery Market for Sleeve Resection, by Region, 2016 – 2028 (USD Million)
TABLE NO. 13. Global Lung Cancer Surgery Market for Endobronchial Surgery, by Region, 2016 – 2028 (USD Million)
TABLE NO. 14. Global Lung Cancer Surgery Market for Pneumonectomy, by Region, 2016 – 2028 (USD Million)
TABLE NO. 15. Global Lung Cancer Surgery Market for Percutaneous Surgery, by Region, 2016 – 2028 (USD Million)
TABLE NO. 16. Global Lung Cancer Surgery Market for Segmentectomy, by Region, 2016 – 2028 (USD Million)
TABLE NO. 17. Global Lung Cancer Surgery Market for Minimally Invasive Surgeries, by Region, 2016 – 2028 (USD Million)
TABLE NO. 18. Global Lung Cancer Surgery Market for Hospitals, by Region, 2016 – 2028 (USD Million)
TABLE NO. 19. Global Lung Cancer Surgery Market for Clinics, by Region, 2016 – 2028 (USD Million)
TABLE NO. 20. Global Lung Cancer Surgery Market for Ambulatory Surgical Centers, by Region, 2016 – 2028 (USD Million)
TABLE NO. 21. Global Lung Cancer Surgery Market for Research Laboratories, by Region, 2016 – 2028 (USD Million)
TABLE NO. 22. Global Lung Cancer Surgery Market Revenue, By Region, 2016 – 2028 (USD Million)
TABLE NO. 23. North America Lung Cancer Surgery Market Revenue, By Country, 2016 – 2028 (USD Million)
TABLE NO. 24. North America Lung Cancer Surgery Market Revenue, By Type, 2016 – 2028 (USD Million)
TABLE NO. 25. North America Lung Cancer Surgery Market Revenue, By Procedure, 2016 – 2028 (USD Million)
TABLE NO. 26. North America Lung Cancer Surgery Market Revenue, By Treatment, 2016 – 2028 (USD Million)
TABLE NO. 27. U.S. Lung Cancer Surgery Market Revenue, By Type, 2016 – 2028 (USD Million)
TABLE NO. 28. U.S. Lung Cancer Surgery Market Revenue, By Procedure, 2016 – 2028 (USD Million)
TABLE NO. 29. U.S. Lung Cancer Surgery Market Revenue, By Treatment, 2016 – 2028 (USD Million)
TABLE NO. 30. Canada Lung Cancer Surgery Market Revenue, By Type, 2016 – 2028 (USD Million)
TABLE NO. 31. Canada Lung Cancer Surgery Market Revenue, By Procedure, 2016 – 2028 (USD Million)
TABLE NO. 32. Canada Lung Cancer Surgery Market Revenue, By Treatment, 2016 – 2028 (USD Million)
TABLE NO. 33. Mexico Lung Cancer Surgery Market Revenue, By Type, 2016 – 2028 (USD Million)
TABLE NO. 34. Mexico Lung Cancer Surgery Market Revenue, By Procedure, 2016 – 2028 (USD Million)
TABLE NO. 35. Mexico Lung Cancer Surgery Market Revenue, By Treatment, 2016 – 2028 (USD Million)
TABLE NO. 36. Drivers for the Lung Cancer Surgery Market: Impact Analysis
TABLE NO. 37. Restraints for the Lung Cancer Surgery Market: Impact Analysis
TABLE NO. 38. Major Buyers of Lung Cancer Surgery
TABLE NO. 39. Distributors/Traders List of Lung Cancer Surgery
TABLE NO. 40. Global Lung Cancer Surgery Market, Company Market Revenue, 2016 – 2019 (USD Million)
TABLE NO. 41. Global Lung Cancer Surgery Market, Company Y-o-Y Growth, 2017 – 2019 (USD Million)
 

Methodology

FrequentlyAsked Questions

According to Zion Market Research, the global Lung Cancer Surgery Market was worth USD 1327.2 Million in 2023. The market is forecast to reach USD 2223.31 Million by 2032.

According to Zion Market Research, the global Lung Cancer Surgery Market a compound annual growth rate (CAGR) of 5.9% during the forecast period 2024-2032.

Some of the key factors driving the Global Lung Cancer Surgery Market growth are increasing senior citizen population, growing pollution due to rising smokers, and increasing women smokers population, among others.

 

North America region held a substantial share of the Lung Cancer Surgery Market in 2020. Asia Pacific to grow at a substantial rate.

Some of the major companies operating in the Cigars and Cigarillos market are Intuitive Surgical, Medical Devices Business Services, Inc., Olympus Corporation, AngioDynamics, Scanlan International, KARL STORZ SE & Co. KG, TROKAMED GmbH, F.Hoffmann-La Roche Ltd., Pfizer Inc., Abbott, Boehringer Ingelheim International GmbH, Genentech Inc., Boston Scientific Corporation, among others.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed